Unraveling the link between insulin resistance and Non-alcoholic fatty liver disease (or metabolic dysfunction-associated steatotic liver disease): A Narrative Review

被引：0
|
作者：
Fateme Ziamanesh
Mehdi Mohammadi
Sholeh Ebrahimpour
Ozra Tabatabaei-Malazy
Asieh Mosallanejad
Bagher Larijani
机构：
[1] Tehran University of Medical Sciences,School of Medicine
[2] Tehran University of Medical Sciences,Non
[3] Alborz University of Medical Sciences,Communicable Diseases Research Center, Endocrinology and Metabolism Population Sciences Institute
[4] Tehran University of Medical Sciences,Department of Clinical Pharmacy, School of Pharmacy
[5] Shahid Beheshti University of Medical Sciences,Endocrinology and Metabolism Research Center, Endocrinology and Metabolism Clinical Sciences Institute
来源：
Journal of Diabetes & Metabolic Disorders | 2023年 / 22卷
关键词：
Insulin resistance; Metabolic Dysfunction-Associated Fatty Liver Disease; Metabolic syndrome; Non-alcoholic Fatty Liver Disease; Type 2 diabetes mellitus;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1083 / 1094
页数：11
相关论文
共 50 条
  • [21] Analysis of non-alcoholic fatty liver disease differences from metabolic dysfunction-associated fatty liver disease based on clinical features
    刘云霄
    [J]. China Medical Abstracts(Internal Medicine), 2024, 41 (03) - 176
  • [22] Impact of the diagnosis of metabolic dysfunction-associated fatty liver disease and non-alcoholic fatty liver disease in patients undergoing liver transplantation for hepatocellular carcinoma
    Zhu, Ji-Qiao
    Liu, Jia-Zong
    Yang, Shi-Wei
    Ren, Zhang-Yong
    Ye, Xiao-Yong
    Liu, Zhe
    Li, Xian-Liang
    Han, Dong-Dong
    He, Qiang
    [J]. FRONTIERS IN ENDOCRINOLOGY, 2024, 15
  • [23] Metabolic dysfunction-associated fatty liver disease (MAFLD) and non-alcoholic fatty liver disease (NAFLD): distinct fatty liver entities with different clinical outcomes?
    Kaya, Eda
    Zedginidze, Aleko
    Bechmann, Lars
    Canbay, Ali
    [J]. HEPATOBILIARY SURGERY AND NUTRITION, 2022, 11 (02) : 299 - 301
  • [24] Liver transplantation in the era of non-alcoholic fatty liver disease/metabolic (dysfunction) associated fatty liver disease: the dilemma of the steatotic liver graft on transplantation and recipient survival
    Gedallovich, Seren M.
    Ladner, Daniela P.
    Van Wagner, Lisa B.
    [J]. HEPATOBILIARY SURGERY AND NUTRITION, 2022, 11 (03) : 425 - 429
  • [25] Metabolic dysfunction-associated steatotic liver disease and the heart
    Driessen, Stan
    Francque, Sven M.
    Anker, Stefan D.
    Cabezas, Manuel Castro
    Grobbee, Diederick E.
    Tushuizen, Maarten E.
    Holleboom, Adriaan G.
    [J]. HEPATOLOGY, 2023,
  • [26] Ferroptosis and metabolic dysfunction-associated fatty liver disease: Is there a link?
    Feng, Gong
    Byrne, Christopher D.
    Targher, Giovanni
    Wang, Fudi
    Zheng, Ming-Hua
    [J]. LIVER INTERNATIONAL, 2022, 42 (07) : 1496 - 1502
  • [27] Metabolic dysfunction-associated steatotic liver disease and atherosclerosis
    Castillo-Nunez, Yulino
    Almeda-Valdes, Paloma
    Gonzalez-Galvez, Guillermo
    Arechavaleta-Granell, Maria del Rosario
    [J]. CURRENT DIABETES REPORTS, 2024, 24 (07) : 158 - 166
  • [28] Menopause and metabolic dysfunction-associated steatotic liver disease
    Polyzos, Stergios A.
    Goulis, Dimitrios G.
    [J]. MATURITAS, 2024, 186
  • [29] Non-alcoholic fatty liver disease and insulin resistance
    Machado, M
    Cortez-Pinto, H
    [J]. EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2005, 17 (08) : 823 - 826
  • [30] Embracing Change: From Nonalcoholic Fatty Liver Disease to Metabolic Dysfunction-Associated Steatotic Liver Disease Under the Steatotic Liver Disease Umbrella
    Noureddin, Mazen
    Wei, Lai
    Castera, Laurent
    Tsochatzis, Emmanuel A.
    [J]. CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2024, 22 (01) : 9 - 11
12345